期刊
BIOPOLYMERS
卷 102, 期 3, 页码 280-287出版社
WILEY-BLACKWELL
DOI: 10.1002/bip.22488
关键词
anti-HIV-1; bone marrow stromal cell antigen 2; Vpu; drug design
资金
- 973 Program [2012CB911102]
- National S&T Major Special Project on Major New Drug Innovation [2012ZX09102101-018]
- Chinese National Natural Science Foundation [81271844]
Bone marrow stromal cell antigen 2 (BST-2) inhibits the release of HIV-1 and other enveloped viruses from the cell surface. HIV-1 Vpu binds to BST-2 through an interaction between transmembrane domains (TMD) of the two proteins and induces the downregulation of cell surface BST-2, thereby counteracting its antiviral activity. In this study, we designed and prepared a modified peptide BST2-TM-P1, which include the sequence of BST-2 TMD, keeping its property competing with BST-2 to bind with Vpu. Biological assay results indicate BST2-TM-P1 could increase the BST-2 level at the cell surface in Vpu dependent manner and significantly inhibit the replication of HIV-1 virion. Our studies indicate that blocking the interaction of Vpu and BST-2 is an effective way to combat HIV-1 infection. (C) 2014 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据